Herceptin+Tykerb may delay cancer's progress
A combination of the breast cancer drugs Herceptin and Tykerb may
slow the progression of the disease, a recent study suggests. In a
study of 300 women, those who received the drug combo went 12 weeks
without their condition worsening, compared to eight weeks in the
women who took Tykerb alone. But researchers say the combination of
drugs also increased the risk of side effects, including a small
decrease in the heart's pumping power.
Read full story >
See all Breast Cancer News
People who read this also read...
What the community is saying...
My Cancer Story
Posted 10/10 Comments (1)
Being diagnosed with breast cancer in 2003 on my birthday was almost the worst day I can remember. The worst day was th...
